Royal Bank of Canada’s Eupraxia Pharmaceuticals EPRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$2.47M	Buy	428,584 +85,756	+25%	+$494K	﹤0.01%	2856
2025 Q1	$1.13M	Buy	342,828 +59,683	+21%	+$196K	﹤0.01%	3067
2024 Q4	$898K	Buy	283,145 +11,858	+4%	+$37.6K	﹤0.01%	3222
2024 Q3	$714K	Buy	271,287 +5,543	+2%	+$14.6K	﹤0.01%	3417
2024 Q2	$686K	Buy	+265,744	New	+$686K	﹤0.01%	3415